The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism

Fertility and Sterility

Volumn 94, Issue 6, 2010, Pages 2214-2221

  Luque Ramírez, Manuel ^b   Alpañés, MacArena ^b   Escobar Morreale, Héctor F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE

Author keywords

abdominal adiposity; glucose tolerance; insulin resistance; Polycystic ovary syndrome; premenopausal women

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER; GLUCOSE; INSULIN; IRON;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERANDROGENISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN DISPOSITION; INSULIN DISPOSITION INDEX; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON STORAGE; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL;

ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; FERRITINS; GLUCOSE INTOLERANCE; HUMANS; HYPERANDROGENISM; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ODDS RATIO; POLYCYSTIC OVARY SYNDROME;

EID: 77957585709     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.11.049     Document Type: Article

References (27)

1. K.E. Salley, E.P. Wickham, K.I. Cheang, P.A. Essah, N.W. Karjane, and J.E. Nestler Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society J Clin Endocrinol Metab 92 2007 4546 4556
2. D. Ehrmann, R. Barnes, R. Rosenfield, M. Cavaghan, and J. Imperial Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146
3. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169
4. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800
5. D.A. Ehrmann, J. Sturis, M.M. Byrne, T. Karrison, R.L. Rosenfield, and K.S. Polonsky Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus J Clin Invest 96 1995 520 527
6. H.F. Escobar-Morreale, M. Luque-Ramirez, and J.L. San Millan The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome Endocr Rev 26 2005 251 282
7. H.F. Escobar-Morreale, and J.L. San Millan Abdominal adiposity and the polycystic ovary syndrome Trends Endocrinol Metab 18 2007 266 272
8. H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, F. Alvarez-Blasco, R. Sanchon, and M. Luque-Ramirez Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study Hum Reprod 21 2006 2257 2265
9. H. Nishizawa, I. Shimomura, K. Kishida, N. Maeda, H. Kuriyama, and H. Nagaretani Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
10. M.A. Martinez-Garcia, M. Luque-Ramirez, J.L. San-Millan, and H.F. Escobar-Morreale Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance and genomic variants related to inflammation, oxidative stress and iron metabolism Diabetes Care 32 2009 1525 1530
11. J.M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-talk between iron metabolism and diabetes Diabetes 51 2002 2348 2354
12. J.K. Zawadzki, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, Polycystic ovary syndrome. Vol. 4 1992 Blackwell Scientific Publications Boston 377 384
13. H.F. Escobar-Morreale, R. Sanchón, and J.L. San Millán A prospective study of the prevalence of nonclassic congenital adrenal hyperplasia (NCAH) among women presenting hyperandrogenic symptoms and signs J Clin Endocrinol Metab 93 2008 527 533
14. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
15. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
16. M.M. Tai A mathematical model for the determination of total area under glucose tolerance and other metabolic curves Diabetes Care 17 1994 152 154
17. R. Retnakaran, S. Shen, A.J. Hanley, V. Vuksan, J.K. Hamilton, and B. Zinman Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test Obesity (Silver Spring) 16 2008 1901 1907
18. American Diabetes Association Position Statement. Diagnosis and classification of diabetes mellitus Diabetes Care 32 2009 S62 S67
19. A. Gambineri, C. Pelusi, E. Manicardi, V. Vicennati, M. Cacciari, and A.M. Morselli-Labate Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors Diabetes 53 2004 2353 2358
20. M.A. Abdul-Ghani, K. Williams, R.A. DeFronzo, and M. Stern What is the best predictor of future type 2 diabetes? Diabetes Care 30 2007 1544 1548
21. J. Vrbikova, T. Grimmichova, K. Dvorakova, M. Hill, S. Stanicka, and K. Vondra Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome Physiol Res 57 2008 547 553
22. H.F. Escobar-Morreale, M. Luque-Ramirez, and J.L. San-Millan Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome Diabetes Care 32 2009 e6
23. K.E. Davis, and P.E. Scherer Adiponectin: no longer the lone soul in the fight against insulin resistance? Biochem J 416 2008 e7 e9
24. J.M. Fernandez-Real, and W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome Endocr Rev 24 2003 278 301
25. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668
26. J.M. Stephens, and P.H. Pekala Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha J Biol Chem 266 1991 21839 21845
27. G.A. Rutter, and L.E. Parton The beta-cell in type 2 diabetes and in obesity Front Horm Res 36 2008 118 134